Attività
Vendite per attività
USD in Milioni | 2019 | Peso | 2020 | Peso | Delta |
---|---|---|---|---|---|
Drug Delivery Systems and Technologies
99,3
%
| - | - | 3 | 99,3 % | - |
Management Services
0,7
%
| - | - | 0 | 0,7 % | - |
Vendite per regione
USD in Milioni | 2019 | Peso | 2020 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 6 | 100,0 % | 3 | 100,0 % | -57,10% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 21/11/17 |
Mark Carrao
DFI | Director of Finance/CFO | - | 01/01/17 |
Terry Thompson
COO | Chief Operating Officer | 65 | 25/06/18 |
Andrew Ro
CIO | Chief Investment Officer | 54 | 21/11/17 |
Chief Administrative Officer | 54 | 12/10/18 | |
Jason Terrell
CTO | Chief Tech/Sci/R&D Officer | 43 | 01/02/17 |
General Counsel | - | 12/02/19 | |
Michelle Starr
SAM | Sales & Marketing | - | 08/01/19 |
Corporate Officer/Principal | - | 08/01/19 | |
Eric von Hofe
PRN | Corporate Officer/Principal | 66 | 01/01/05 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Brian T. McGee
BRD | Director/Board Member | 63 | 01/03/04 |
Eric von Hofe
PRN | Corporate Officer/Principal | 66 | 01/01/05 |
Craig Eagle
BRD | Director/Board Member | 57 | 21/11/17 |
Joseph Moscato
CEO | Chief Executive Officer | 61 | 21/11/17 |
Andrew Ro
CIO | Chief Investment Officer | 54 | 21/11/17 |
Director/Board Member | 73 | 08/04/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 122 058 444 | 122 058 444 ( 100,00 %) | 0 | 100,00 % |
Coordinate società
Settore
Vendite per attività
Variaz. 1 gen. | Capi. | |
---|---|---|
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |